Davis Polk advised the joint book-running managers and representatives of the several underwriters in the offering. IVERIC bio Inc. executed a $173.4 million SEC-registered offering of 10,350,000 shares...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the sales agent on the offering. Boston Omaha Corporation completed the offering of its shares of Class A common stock for up to...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the sales agent on the deal. Inventiva S.A., a clinical-stage biotechnological company, announced the implementation of an At-The-Market (“ATM”) program allowing the Company to...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Comcast Corporation in the offering, while Cahill represented the underwriters. Comcast Corporation executed its debt offering of €1.25 billion aggregate principal amount of its...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the representatives of the several underwriters in the offering. Akoya Biosciences, Inc. executed its $151.3 million initial public offering of 7,567,000 shares of common...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the joint book-running managers in the offering. Solid Biosciences Inc. executed the $143.75 million public offering of common stock. The common stock is listed...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the representatives of the several underwriters on the offering. Anthem, Inc. executed its offering of $3.5 billion in aggregate principal amount of unsecured and...
You must be a Standard 1 Year member to access this content.
